CytomX Therapeutics Logo

CytomX Therapeutics

🇺🇸
CTMX
US23284F1057

CytomX Therapeutics is a U.S.-based biotechnology company specializing in the development of innovative cancer therapies. Through its proprietary Probody technology, the company enables precision-targeted oncology to spare healthy tissue while effectively combating tumors.

Next Quarterly Earnings

Tuesday, November 10, 2026
CW 46
After-Hours
In 75 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 13, 2026

Stock Price

Frequently asked questions

When will CytomX Therapeutics report its next quarterly earnings?

CytomX Therapeutics is scheduled to report its next quarterly earnings on 11/10/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did CytomX Therapeutics last report quarterly earnings?

CytomX Therapeutics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.09 USD.

How does CytomX Therapeutics stock react to earnings?

Across its last 3 earnings reports, CytomX Therapeutics stock moved by ±15.8% on average the following day. The largest reaction was +44.2% on 03/16/2026; 2 of 3 reactions were positive.

How often has CytomX Therapeutics beaten expectations?

CytomX Therapeutics has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).

How do I add the CytomX Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.07
Actual:
Q2 2026
Missed
Estimate:-$0.08
Actual:-$0.09
Difference:-$0.01
Price reaction (1 day):+2.7 %
Price reaction (7 days):+0.7 %
Q1 2026
Beat
Estimate:-$0.12
Actual:-$0.10
Difference:+$0.02
Price reaction (1 day):-0.5 %
Price reaction (7 days):-5.5 %
Q4 2025
Missed
Estimate:-$0.09
Actual:-$0.17
Difference:-$0.08
Price reaction (1 day):+44.2 %
Price reaction (7 days):-4.7 %
Q2 2025
Missed
Estimate:-$0.04
Actual:-$0.09
Difference:-$0.05
Q1 2025
Beat
Estimate:-$0.06
Actual:$0.00
Difference:+$0.06

Earnings statistics

Stock reaction to earnings

±15.8%
Avg. next-day move
+44.2%
Largest move (03/16/2026)
66.7%
Share of positive reactions
±3.6%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Estimates vs. results

2/5
Quarters above estimates
40%
Beat rate
-16.9%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
CytomX Therapeutics
Ticker Symbol
CTMX
ISIN
US23284F1057
Country
🇺🇸
USA
Sector